IDEAS home Printed from https://ideas.repec.org/a/adm/journl/v7y2018i1p31-38.html
   My bibliography  Save this article

Characterization and Evaluation of Vernonia amygdalina Extracts for its Antidiabetic Potentials

Author

Listed:
  • Adewole Ezekiel
  • Ojo A
  • Ogunmodede O.T
  • Adewumi D.F
  • Omoaghe A.O
  • Jamshed I

Abstract

Background: There is increase in the demand for the use of medicinal plants for the treatment of various ailments such as cancer, hypertension and diabetes locally as a result of the inability of the synthesized drugs to completely eradicate the ailments and also with the attendant side effects attached to the use of drugs. Objective: The aim of this research work was to investigate the Aldose reductase, α-glucosidase, β -glucosidase and maltase glucoamylase inhibitory potential of the crude extracts of Vernonia amygdalina, and characterizing the extracts. Materials and method: The leaves of the plant was obtained, air dried and turned to powdered form using commercial grinding machine with dimension 34×38×75. The extracted crudes were subjected into in-vitro studies of the inhibitory potentials using recommended protocols. The IC50 values were calculated using Graph pad prism 5.0 software and the identified compounds were screened for drug properties using ONLINE OSIRIS server explorer. Results: The (IC50 0.6 ± 0.03 μg/mL) of the chloroform extract was better than the methanolic extract of IC50 (1.532±0.63μg/mL) and the results were better than the acarbose standard (IC50 234.6 + 2.01μM). The maltase glucoamylase inhibitory potentials of the chloroform and methanolic extracts in the range of IC50 1.112 ± 0.90 μg/mL and 1.315 ± 0.7 μg/mL. The β-glucosidase screening of the extracts results indicated that they do not have good selective inhibitor properties. IC50 of Aldose reductase (ALR2) of chloroform extract IC50 (1.339+0.264μg/mL) was better than that of methanolic extract of IC50 (1.437+0.6μg/mL) and these values were better when compared with the standard, sorbinil of IC50 (3.10 +0.20μM).The aldehyde reductase (ALR1) of methanolic extract IC50 (0.325+0.02μg/mL) was better than that of chloroform extract of IC50 (0.964+0.16μg/mL) and when compared with standard 10mM vaproic acid IC50 (57.4 +10μM).The GC-MS of the chloroform extract revealed compounds which were screened computationally to for various drug properties such as drug likeness, cLogS, cLogP, H-bond acceptor and H-bond Donor. Conclusion: The promising inhibitory potential of the plant extracts and characterization of the extract is an indication of the usefulness of the plant for the treatment of diabetes.

Suggested Citation

  • Adewole Ezekiel & Ojo A & Ogunmodede O.T & Adewumi D.F & Omoaghe A.O & Jamshed I, 2018. "Characterization and Evaluation of Vernonia amygdalina Extracts for its Antidiabetic Potentials," International Journal of Sciences, Office ijSciences, vol. 7(01), pages 31-38, January.
    • Handle: RePEc:adm:journl:v:7:y:2018:i:1:p:31-38
    DOI: 10.18483/ijSci.1462
    as

    Download full text from publisher

    File URL: https://www.ijsciences.com/pub/article/1462
    Download Restriction: no
    File URL: https://www.ijsciences.com/pub/pdf/V72018011462.pdf
    Download Restriction: no
    File URL: https://libkey.io/10.18483/ijSci.1462?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Wenhua Zhu & Mengyuan Wang & Zhifei Wang & Ming Hu & Bin Wang & Dongmeng Qian, 2018. "Construction and Identification of Transgenic Mice Carrying Human Cytomegalovirus IE2 Gene," International Journal of Sciences, Office ijSciences, vol. 7(01), pages 84-89, January.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:adm:journl:v:7:y:2018:i:1:p:31-38. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Staff ijSciences (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.